Offerings Archives - Page 17 of 166

2 minute read

Tevogen Bio Entered Into A Securities Purchase Agreement With An Investor Pursuant To Which The Investor Agreed To Purchase Shares Of Series A Preferred Stock Of The Company For An Aggregate Purchase Price Of $8M

February 15, 10:26 AM

On February 14, 2024, Tevogen Bio Holdings Inc. (the "Company") (NASDAQ:TVGN), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in virology,

TVGN

1 minute read

Vivos Therapeutics Announces Exercise Of Warrants For ~$4M Aggregate Gross Proceeds

By Benzinga Newsdesk

February 15, 9:04 AM

Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ:VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for

VVOS

1 minute read

Bakkt Shelf Registration Statement Declared Effective By The SEC; Registration Statement Allows Bakkt, So Long As It Is Effective, To Raise Up To An Aggregate Of $150M Of Capital In One Or More Offerings Over The Subsequent 3-Years

By Benzinga Newsdesk

February 14, 7:55 PM

Bakkt Holdings, Inc. ("Bakkt") (NYSE:BKKT) announced that its "universal shelf" registration statement on Form S-3 was declared effective by the Securities and Exchange Commission (the "SEC") on February 14, 2024. This

BKKT

1 minute read

Prime Medicine Announces $125M Proposed Public Offering Of Common Stock

By Benzinga Newsdesk

February 14, 5:36 PM

Prime Medicine, Inc. (NASDAQ:PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that it has commenced an underwritten public offering

PRME

1 minute read

Unusual Machines Announces Pricing Of $5M Initial Public Offering Of 1.25M Shares Of Common Stock At A Price Of $4/Share

By Benzinga Newsdesk

February 14, 10:02 AM

Unusual Machines, Inc. ("Unusual Machines" or the "Company"), an emerging leader in first-person view (FPV) drone technology, announced today the pricing of its initial public offering (the "Offering") of 1,250,000

UMAC

3 minute read

AAR Announces Update To Financing Of Triumph Product Support Acquisition Of Triumph Group’s Product Support Business; Announces Proposed Offering Of $500M Of Senior Notes Due 2029

By Benzinga Newsdesk

February 14, 9:56 AM

Announces proposed offering of $500 million of senior notes due 2029The acquisition will be financed with the proceeds from the proposed notes offering and use of the expanded revolverWOOD DALE, Ill., Feb. 14, 2024

AIR

1 minute read

ToughBuilt Industries Announces Pricing Of $3.5M Public Offering Of 772,628 Shares Of Its Common Stock At A Price Of $4.53/Share

By Benzinga Newsdesk

February 14, 9:07 AM

ToughBuilt Industries, Inc. ("ToughBuilt" or the "Company") (NASDAQ:TBLT, TBLTW)))), today announced the pricing of a public offering of 772,628 shares of its common stock (or pre-funded warrants in lieu thereof),

TBLT

1 minute read

Larimar Therapeutics Announces Proposed Underwritten Public Offering; No Size Or Amount Disclosed

By Benzinga Newsdesk

February 13, 5:54 PM

Larimar Therapeutics, Inc. ("Larimar") (NASDAQ:LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that it has commenced an underwritten public

LRMR

1 minute read

Immunome Announces Proposed $200M Public Offering of Common Stock

By Benzinga Newsdesk

February 13, 5:42 PM

Immunome, Inc. ("Immunome") (NASDAQ:IMNM), a biotechnology company dedicated to developing first-in-class and best-in-class targeted cancer therapies, today announced its plans to commence an underwritten public

IMNM

2 minute read

REV Group, Inc. Announces Proposed Secondary Offering Of 12M Shares Of Common Stock And Concurrent Share Repurchase

By Benzinga Newsdesk

February 13, 5:40 PM

REV Group, Inc. (NYSE:REVG) announced today the commencement of an underwritten public offering of 12,000,000 shares of common stock by certain selling stockholders. In connection with the offering, the selling

REVG